Featured News

We are determined to use every resource at our disposal, including strategic funding of research and advocacy, to help discover and bring to the celiac disease patient community therapeutic alternatives to the gluten-free diet.

The Celiac Disease Foundation is proud to announce its sponsorship of the April 17th University of Chicago’s Celiac Disease & The Continuum of Care Virtual CME Symposium.

9 Meters Biopharma, Inc., a clinical-stage company focused on rare and unmet needs in gastroenterology, announced their collaboration with the Celiac Disease Foundation to support clinical trial enrollment.

For the second consecutive year, the Celiac Disease Foundation hosted the Patient Education & Advocacy Summit.

The NIH Accelerating Progress in Celiac Disease Workshop is a direct outcome of our advocacy efforts in Washington, DC. CEO Marilyn Geller was invited to speak about what our celiac community needs. Watch her presentation here.

We are pleased to share that CEO Marilyn Geller will be presenting as the Patient Advocate at the March 18-19 National Institute of Allergy and Infectious Diseases Accelerating Progress in Celiac Disease Workshop. We encourage you to register to attend this seminal virtual meeting.

Thank you to Cabinet for sponsoring our upcoming Patient Education and Advocacy Summit. Built from three generations of medicine manufacturing and health care experience, Cabinet provides high-quality and fairly priced medicines directly to your door. Sourced from world-class, ethical manufacturers, every single bottle is batch-level tested and 100% certified gluten-free. Register now to be a part of this important event!

Thank you to Provention Bio, Inc., for supporting our upcoming Patient Education and Advocacy Summit. Provention Bio, Inc., is a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases. Register now to be a part of this monumental event!

Initial findings of the first mass screening study for U.S. children show a high prevalence of celiac disease autoimmunity (CDA) among those without symptoms and no family history of the condition.

The Senate Appropriations Committee has released their FY2021 funding recommendations, which includes report language directing NIH to support celiac disease research.